Gilead Sciences, Inc. Announces Second Quarter 2013 Financial Results

Published: Jul 26, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended June 30, 2013. Total revenues for the second quarter of 2013 increased 15 percent to $2.77 billion, from $2.41 billion for the second quarter of 2012. Product sales increased 14 percent to $2.66 billion for the second quarter of 2013 compared to $2.32 billion for the second quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.

Back to news